Potential Anticancer Effects of Isoflavone Prunetin and Prunetin Glycoside on Apoptosis Mechanisms

Int J Mol Sci. 2024 Oct 31;25(21):11713. doi: 10.3390/ijms252111713.

Abstract

Cancer is a deadly disease caused by cells that deviate from the normal differentiation and proliferation behaviors and continue to multiply. There is still no definitive cure, and many side effects occur even after treatment. However, apoptosis, one of the programs imprinted on cells, is becoming an important concept in controlling cancer. Flavonoids are polyphenolic compounds found in plants, are naturally bioactive compounds, have been studied for their anticancer effects, and have fewer side effects than chemical treatments. Isoflavones are phytoestrogens belonging to the flavonoid family, and this review discusses in depth the potential anticancer effects of prunetin, one of the many flavonoid families, via the apoptotic mechanism. In addition, a glycoside called prunetin glucoside has been investigated for its anticancer effects through apoptotic mechanisms. The primary intention of this review is to identify the effects of prunetin and its glycoside, prunetin glucoside, on cell death signaling pathways in various cancers to enhance the potential anticancer effects of these natural compounds.

Keywords: anticancer; apoptosis; isoflavone; prunetin glucosides; signaling pathway.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Apoptosis* / drug effects
  • Glycosides / pharmacology
  • Humans
  • Isoflavones* / chemistry
  • Isoflavones* / pharmacology
  • Neoplasms* / drug therapy
  • Neoplasms* / metabolism
  • Neoplasms* / pathology
  • Signal Transduction / drug effects

Substances

  • Isoflavones
  • prunetin
  • Glycosides
  • Antineoplastic Agents

Grants and funding

This study was supported by the National Research Foundation of Korea, funded by the Ministry of Science and ICT (grant Nos. RS-2023-00243376 and RS-2024-00411709).